CAS 189261-10-7: Immunoglobulin G4, anti-(human integrin α4) (human-mouse monoclonal AN100226 γ4-chain), disulfide with human-mouse monoclonal AN100226 light chain, dimer
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Natalizumab REF: TM-T12177CAS: 189261-10-7 | 98.00% | 166,00 €~948,00 € | Lun 10 Mar 25 |
 | Natalizumab REF: 3D-FN139133CAS: 189261-10-7 | Min. 95% | 1.446,00 € | Lun 14 Abr 25 |
Natalizumab
CAS:189261-10-7
Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.
Pureza:
98.00%
Forma y color:
Liquid
Peso molecular:
N/A
Ref: TM-T12177
| 1mg | 166,00 € | ||
| 2mg | 236,00 € | ||
| 5mg | 404,00 € | ||
| 10mg | 648,00 € | ||
| 25mg | 948,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
Natalizumab
CAS:189261-10-7
Monoclonal antibody against α4-integrin
Fórmula:
C40H55N7O11S
Pureza:
Min. 95%
Peso molecular:
841.97
Ref: 3D-FN139133
| 1mg | 1.446,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
